Clinical Trial Update: A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and efficacy of adding various oral hypoglycemics to sitagliptin + metformin in Chinese patients with type 2 diabetes; results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Acarbose (acarbose)
• Gliclazide (gliclazide)
• Glimepiride (glimepiride)
• Repaglinide (Repaglinide)
• Sitagliptin/metformin (sitagliptin/metformin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2016-05-11